Summary by Moomoo AI
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the filing of its definitive proxy statement with the SEC, scheduling its annual meeting of stockholders for May 16, 2024. The meeting, to be held virtually, will allow stockholders to elect eleven board nominees, ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 29, 2024, and vote on an advisory resolution to approve executive compensation. The Board unanimously recommends voting for all proposals. Stockholders as of the record date, March 22, 2024, are entitled to vote. The proxy materials are available at www.proxyvote.com, and stockholders can vote via the internet, telephone, or mail prior to the meeting. The Board also addressed the anticipated divestiture of GRAIL, aiming to finalize terms by the second quarter of 2024. The proxy statement includes compensation details for named executive officers, with CEO Jacob Thaysen's compensation package reflecting stockholder feedback on performance alignment.